NVDA
NVIDIA
-- 131.760 TSLA
Tesla
-- 396.360 RGTI
Rigetti Computing
-- 8.9500 AMD
Advanced Micro Devices
-- 116.090 PLTR
Palantir
-- 65.910 
NEWS
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
Crown Laboratories and Revance Therapeutics (NASDAQ: RVNC) have announced an amended merger agreement where Crown will acquire all outstanding Revance shares for $3.10 per share in cash through a tender offer. The amendment comes after several developments, including Revance's settlement with Teoxane regarding distribution agreements and revised brand guidelines, which are expected to materially impact Revance's future profitability.
The transaction is anticipated to close in Q1 2025, subject to stockholders tendering shares representing at least a majority of Revance's voting power. Post-merger, Revance will become wholly owned by Crown and will be delisted from Nasdaq. The tender offer is expected to commence on December 12, 2024, with Revance's Board unanimously recommending stockholders to tender their shares.
Crown Laboratories and Revance Therapeutics (NASDAQ: RVNC) have announced an amended merger agreement where Crown will acquire all outstanding Revance shares for $3.10 per share in cash through a tender offer. The amendment comes after several developments, including Revance's settlement with Teoxane regarding distribution agreements and revised brand guidelines, which are expected to materially impact Revance's future profitability.
The transaction is anticipated to close in Q1 2025, subject to stockholders tendering shares representing at least a majority of Revance's voting power. Post-merger, Revance will become wholly owned by Crown and will be delisted from Nasdaq. The tender offer is expected to commence on December 12, 2024, with Revance's Board unanimously recommending stockholders to tender their shares.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
6645
Followers
44
Following
71K
Visitors
Follow
Discussing
Trump 2.0 countdown: What's the next big opportunity in the markets?
🎙️️ Discussion: 1. Could Trump's cryptocurrency policies potentially benefit the crypto market? 2. Might his tariff policies have a positiv
Popular on moomoo
Jan 13 17:43
Trump 2.0 Opportunity Preview: Guess the market winner before the president takes office!